HWAM
SAGE

Hennion & Walsh Asset Management’s Sage Therapeutics SAGE Stock Holding History

Hennion & Walsh Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,828
Closed -$118K – 949
2025
Q1 		$118K Sell
14,828
-3,418
-19% -$25K 0.01% 853
2024
Q4 		$99.1K Sell
18,246
-21,172
-54% -$129K ﹤0.01% 841
2024
Q3 		$285K Sell
39,418
-2,419
-6% -$22.1K 0.01% 748
2024
Q2 		$454K Sell
41,837
-24,730
-37% -$317K 0.02% 613
2024
Q1 		$1.25M Buy
66,567
+5,068
+8% +$117K 0.07% 368
2023
Q4 		$1.33M Sell
61,499
-23,996
-28% -$476K 0.08% 334
2023
Q3 		$1.76M Buy
85,495
+4,262
+5% +$123K 0.11% 234
2023
Q2 		$3.82M Buy
81,233
+8,476
+12% +$422K 0.23% 112
2023
Q1 		$3.05M Buy
72,757
+1,740
+2% +$74.8K 0.19% 139
2022
Q4 		$2.71M Sell
71,017
-9,373
-12% -$358K 0.17% 157
2022
Q3 		$3.15M Buy
80,390
+1,972
+3% +$76.2K 0.21% 134
2022
Q2 		$2.53M Buy
78,418
+15,866
+25% +$532K 0.16% 167
2022
Q1 		$2.07M Buy
62,552
+10,264
+20% +$386K 0.11% 218
2021
Q4 		$2.22M Buy
52,288
+14,393
+38% +$603K 0.11% 220
2021
Q3 		$1.68M Sell
37,895
-835
-2% -$38.3K 0.09% 260
2021
Q2 		$2.2M Sell
38,730
-421
-1% -$29.8K 0.12% 234
2021
Q1 		$2.93M Buy
+39,151
New +$3.21M 0.18% 165

Other funds holding SAGE

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Hennion & Walsh Asset Management's SAGE Position: Q2 2025 in Review

Hennion & Walsh Asset Management sold out of Sage Therapeutics (SAGE) in Q2 2025, closing a stake of 14,828 shares — an estimated $118K sold.

Hennion & Walsh Asset Management first reported a position in SAGE in Q1 2021 and held it in 17 quarters. The position peaked at $3.82M in Q2 2023. 192 funds tracked by Wall St. Rank hold SAGE as of Q2 2025.

  • Hennion & Walsh Asset Management reported no remaining Sage Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 14,828 Sage Therapeutics shares in Q2 2025, an estimated $118K.
  • Hennion & Walsh Asset Management first reported a position in Sage Therapeutics in Q1 2021 and held it in 17 quarters.
  • Hennion & Walsh Asset Management's Sage Therapeutics position peaked at $3.82M in Q2 2023.
  • 192 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2025.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.